Literature DB >> 12742266

Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma.

Annet Waaijer1, Chris H J Terhaard, Human Dehnad, Gerrit-Jan Hordijk, Maarten S van Leeuwen, Cornelius P J Raaymakers, Jan J W Lagendijk.   

Abstract

BACKGROUND AND
PURPOSE: Waiting lists for radiotherapy have become longer over the past years. Apart from the psychological distress for the patient we are concerned about tumour growth during this waiting time, which may worsen prognosis. The purpose of this pilot study was to investigate tumour growth in the waiting time and to obtain an indication of its clinical consequences for patients with oropharyngeal carcinoma. A tumour control probability (TCP) model was applied to evaluate consequences for outcome. METHODS AND MATERIALS: Increase in tumour volume was measured for 13 patients with oropharyngeal carcinoma by outlining the tumour on the diagnostic as well as on the treatment planning CT scan. Waiting time was defined as time between histopathological diagnosis and start of radiotherapy. For each tumour we calculated the increase in tumour volume and the tumour doubling time. The potential increase in TCP was calculated for each tumour for the situation without treatment delay.
RESULTS: The mean increase in tumour volume was 70%. The mean waiting time was 56 days. Expected TCP with incorporation of delay was 47%, without delay it might have been 63-66%.
CONCLUSION: This study shows tumour progression during the time between the diagnostic CT scan and the treatment planning CT scan in oropharyngeal cancer. As a consequence of waiting time, which allows tumour volume increase, there may be an average control loss of 16-19 % for these tumours during the total waiting time before radiotherapy.

Entities:  

Mesh:

Year:  2003        PMID: 12742266     DOI: 10.1016/s0167-8140(03)00036-7

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  30 in total

1.  Waiting for radiotherapy.

Authors:  D Dodwell; A Crellin
Journal:  BMJ       Date:  2006-01-14

2.  The effect of time between diagnosis and initiation of treatment on outcomes in patients with head and neck squamous cell carcinoma.

Authors:  Luke H DeGraaff; Alexis J Platek; Austin J Iovoli; Kimberly E Wooten; Hassan Arshad; Vishal Gupta; Ryan P McSpadden; Moni Abraham Kuriakose; Wesley L Hicks; Mary E Platek; Anurag K Singh
Journal:  Oral Oncol       Date:  2019-07-30       Impact factor: 5.337

3.  Organ preservation in locally advanced head and neck cancer of the larynx using induction chemotherapy followed by improved radiation schemes.

Authors:  Giovanni Franchin; Emanuela Vaccher; Doriano Politi; Emilio Minatel; Carlo Gobitti; Renato Talamini; Simon Spazzapan; Maria Gabriella Savignano; Mauro G Trovò; Luigi Barzan
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-09-09       Impact factor: 2.503

4.  Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma.

Authors:  Sonam Sharma; Justin Bekelman; Alexander Lin; J Nicholas Lukens; Benjamin R Roman; Nandita Mitra; Samuel Swisher-McClure
Journal:  Oral Oncol       Date:  2016-03-16       Impact factor: 5.337

Review 5.  Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers.

Authors:  Muhammad M Fareed; Rizwan Ishtiaq; Thomas J Galloway
Journal:  Curr Treat Options Oncol       Date:  2018-03-12

6.  Treatment and Outcomes of Oropharyngeal Cancer in People with Human Immunodeficiency Virus.

Authors:  Cristina E Brickman; Kathleen J Propert; Jessica S Merlin; Jeffrey C Liu; Sequoya Eady; Amy Mcghee-Jez; Camille Ragin; Surbhi Grover; Roger B Cohen; Robert Gross
Journal:  AIDS Res Hum Retroviruses       Date:  2019-08-29       Impact factor: 2.205

7.  Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.

Authors:  Colin T Murphy; Thomas J Galloway; Elizabeth A Handorf; Brian L Egleston; Lora S Wang; Ranee Mehra; Douglas B Flieder; John A Ridge
Journal:  J Clin Oncol       Date:  2015-11-30       Impact factor: 44.544

8.  Making molehills out of a mountain: experience with a new scheduling strategy to diminish workload variations in response to increased treatment demands.

Authors:  A Waters; M Alizadeh; C Filion; F Ashbury; J Pun; M P Chagnon; A Legrain; M A Fortin
Journal:  Curr Oncol       Date:  2016-08-12       Impact factor: 3.677

9.  Impact of Time Factors on Outcome in Patients with Head and Neck Cancer Treated with Definitive Radio(Chemo)Therapy.

Authors:  Sören Dahlke; Diana Steinmann; Hans Christiansen; Martin Durisin; Andre Eckardt; Gerd Wegener; Michael Bremer; Andreas Meyer
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

10.  What are the real waiting times for therapeutic management of head and neck cancer: a study in the general population in the north-west of France.

Authors:  Anne-Valerie Guizard; Olivier Dejardin; Ludivine Launay; Simona Bara; Bénédicte Lapôtre-Ledoux; Emmanuel Babin; Guy Launoy; Karine Ligier
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-27       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.